The EAVE II team is committed to openness and transparency. Key information such as the study protocol, statistical analysis plan and code used in analyses are available on this website. Study Protocol Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II): Protocol for an Observational Study using Linked Scottish National Data Simpson CR, Robertson C, Vasileiou E, et al BMJ Open (2020). doi: https://doi.org/10.1136/bmjopen-2020-039097 Read the EAVE II protocol, published in the BMJ, June 2020 Statistical Analysis Plans The EAVE II team rapidly reacts to focus on work required to inform policy as the dynamics of the pandemic and vaccine delivery change over time. As we do so, we will publish details of individual analysis plans here. Document EAVE II SAP for first and second dose vaccine waning 15 March 2021 (580.55 KB / PDF) Document Analysis plan for programmatic evaluation of COVID-19 vaccination against hospitalisations in adults (April 23, 2021) (157.22 KB / PDF) Document Analysis plan for programmatic evaluation of COVID-19 vaccination against mortality in adults (April 23, 2021) (127.3 KB / PDF) Code available in EAVE II GitHub repository Code used in our analyses are available via the EAVE II GitHub site This article was published on 2024-09-24
